New study tests two-step surgery to delay menopause while cutting ovarian cancer risk

NCT ID NCT01907789

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at three approaches to prevent ovarian cancer in women with BRCA1 or BRCA2 gene mutations: regular screening, removing both fallopian tubes and ovaries at once, or removing only the fallopian tubes first and the ovaries later. The two-step surgery aims to delay menopause and its side effects. About 80 premenopausal women aged 30-47 are taking part to see how many complete the delayed ovary removal and whether the fallopian tube removal alone lowers cancer risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NorthShore University Health System

    Evanston, Illinois, 60201, United States

  • University of Texas MD Anderson Cancer Center

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.